Danitracen

Danitracen

SCHEMBL21646077

CN1CCC(=C2c3ccccc3C(O)c3ccccc32)CC1.CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Danitracen. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH1 known ✓ P35367 4/20 0.75
▸ SETD7 Q8WTS6 7/20 0.75
▸ CHRM2 P08172 5/20 0.75
▸ CHRM1 P11229 5/20 0.75
▸ ADRA1A P35348 5/20 0.75
▸ KCNH2 Q12809 5/20 0.75
▸ HTR1A P08908 4/20 0.75
▸ ADRA2A P08913 4/20 0.75
▸ DRD1 P21728 4/20 0.75
▸ DRD3 P35462 4/20 0.75
▸ HTR2A P28223 4/20 0.75
▸ HTR2C P28335 4/20 0.75
▸ HTR2B P41595 4/20 0.75
▸ SLC6A2 P23975 3/20 0.75
▸ SLC6A4 P31645 3/20 0.75
▸ SLC6A3 Q01959 3/20 0.75
▸ CYP2D6 P10635 3/20 0.75
▸ CYP2C19 P33261 3/20 0.75
▸ DRD2 P14416 3/20 0.75
▸ ADRA2B P18089 3/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Danitracen SCHEMBL29387690 0.91 SETD7 (0.67) SETD7CHRM2CHRM1ADRA1AKCNH2
Danitracen SCHEMBL2734228 0.91 SETD7 (0.67) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL29369949 0.87 SETD7 (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL4021 0.87 SETD7 (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL7923153 0.87 SETD7 (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL41842 0.85 LMNA (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL20610743 0.85 LMNA (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL30772122 0.85 LMNA (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL5500354 0.85 LMNA (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2
Cyproheptadine SCHEMBL29380652 0.85 LMNA (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210308052-A1 SUSTAINED-RELEASE COMPOSITIONS COMPRISING A THERAPEUTIC AGENT FOR TREATING DEPRESSION OR ANXIETY AND USES THEREOF TAIWAN LIPOSOME CO., LTD. (TW) 2021-10-07 — — US claimed
EP-3829539-A1 SUSTAINED-RELEASE COMPOSITIONS COMPRISING A THERAPEUTIC AGENT FOR TREATING DEPRESSION OR ANXIETY AND USES THEREOF Taiwan Liposome Company, Ltd. (TW) 2021-06-09 — — EP claimed
WO-2020028475-A1 SUSTAINED-RELEASE COMPOSITIONS COMPRISING A THERAPEUTIC AGENT FOR TREATING DEPRESSION OR ANXIETY AND USES THEREOF TAIWAN LIPOSOME CO., LTD. (CN) 2020-02-06 — — WO claimed
US-12005142-B2 Sustained-release compositions comprising a therapeutic agent for treating depression or anxiety and uses thereof TAIWAN LIPOSOME CO., LTD. (TW) 2024-06-11 — — US disclosed
US-20210308052-A1 SUSTAINED-RELEASE COMPOSITIONS COMPRISING A THERAPEUTIC AGENT FOR TREATING DEPRESSION OR ANXIETY AND USES THEREOF TAIWAN LIPOSOME CO., LTD. (TW) 2021-10-07 — — US disclosed
EP-3829539-A1 SUSTAINED-RELEASE COMPOSITIONS COMPRISING A THERAPEUTIC AGENT FOR TREATING DEPRESSION OR ANXIETY AND USES THEREOF Taiwan Liposome Company, Ltd. (TW) 2021-06-09 — — EP disclosed
WO-2020028475-A1 SUSTAINED-RELEASE COMPOSITIONS COMPRISING A THERAPEUTIC AGENT FOR TREATING DEPRESSION OR ANXIETY AND USES THEREOF TAIWAN LIPOSOME CO., LTD. (CN) 2020-02-06 — — WO disclosed
Send feedback